Exicure (XCUR) Other Operating Expenses (2020 - 2025)

Exicure (XCUR) reported Other Operating Expenses of $6.0 million for Q1 2025, up 549.35% quarter-over-quarter from $920000.0 in Q3 2023.

Exicure (XCUR) Other Operating Expenses (2020 - 2025) Analysis & Trends

Exicure has reported Other Operating Expenses for 3 years, with the latest figure at $6.0 million in Q1 2025.

For the quarter ending Q1 2025, Other Operating Expenses changed N/A year-over-year to $6.0 million; the trailing twelve-month figure through Dec 2025 stood at $6.0 million (changed N/A YoY), and the FY2025 full-year result was $6.0 million, changed N/A from the prior year.
Other Operating Expenses for Q1 2025 stood at $6.0 million, up from $920000.0 in the prior quarter.
The five-year high for Other Operating Expenses was $6.0 million in Q1 2025, with the low at $920000.0 in Q3 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	719,706.53 Bn	719,706.50 Bn	-
2	Belite Bio	55,800.00 Bn	55,800.00 Bn	-
3	Quantum Biopharma	18,182.30 Bn	18,182.29 Bn	-
4	Legend Biotech	3,154.00 Bn	3,153.71 Bn	242.10 Mn
5	Akari Therapeutics	1,844.30 Bn	1,844.29 Bn	-
6	Evaxion A	1,567.96 Bn	1,567.94 Bn	-
7	Psyence Biomedical	251.43 Bn	251.42 Bn	-
8	Vertex Pharmaceuticals	112.56 Bn	105.31 Bn	2.59 Bn
9	Abivax	94.37 Bn	94.37 Bn	-
10	Exicure	19.38 Mn	16.77 Mn	-

Download Data